4.7 Article

Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Low-Level Rifampin Resistance and rpoB Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York

Joseph Shea et al.

Summary: Rapid and reliable detection of rifampin resistance is crucial for tuberculosis treatment, but low-level resistance strains may be missed by routine testing, highlighting the importance of whole-genome sequencing in identifying these strains.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Editorial Material Microbiology

On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex

Claudio U. Koser et al.

Summary: The World Health Organization has lowered the clinical concentration of rifampin for tuberculosis testing, prompting discussions on the need for calibrated methods against rigorously defined reference standards.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Letter Respiratory System

Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown

Armand Van Deun et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Infectious Diseases

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis

Ma-chao Li et al.

Summary: The study identified 34 mutations within the rpoB gene, with 25 of them altering structural interactions with RIF and contributing to resistance. Specific mutations such as S450L, H445D, H445Y, H445R were associated with high-level resistance, while D435V was linked to moderate resistance.

INFECTION AND DRUG RESISTANCE (2021)

Review Respiratory System

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

Emanuele Pontali et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Review Respiratory System

Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management

Emanuele Pontali et al.

CURRENT OPINION IN PULMONARY MEDICINE (2018)

Article Respiratory System

Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea

Kyung-Wook Jo et al.

TUBERCULOSIS AND RESPIRATORY DISEASES (2017)

Article Infectious Diseases

Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex

Zenda L. Berrada et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)

Article Microbiology

Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis

F. B. Jamieson et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Article Microbiology

Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard

Armand Van Deun et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2013)

Article Multidisciplinary Sciences

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks

Frederick A. Sirgel et al.

PLOS ONE (2013)

Article Medical Laboratory Technology

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System

Won-Jung Koh et al.

ANNALS OF LABORATORY MEDICINE (2012)